Table of Contents USA Pulmonary Drug Delivery Devices Market Report 2012-2023 1 Pulmonary Drug Delivery Devices Overview 1.1 Product Overview and Scope of Pulmonary Drug Delivery Devices 1.2 Classification of Pulmonary Drug Delivery Devices by Product Category 1.2.1 USA Pulmonary Drug Delivery Devices Sales (K Units) Comparison by Types (2012-2023) 1.2.2 USA Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Types in 2017 1.2.3 Dry Powder Inhaler 1.2.4 Metered Dose Inhaler 1.2.5 Nebulizer 1.3 USA Pulmonary Drug Delivery Devices Market by Application/End Users 1.3.1 USA Pulmonary Drug Delivery Devices (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Asthma 1.3.3 COPD 1.3.4 Cystic Fibrosis 1.3.5 Other 1.4 USA Pulmonary Drug Delivery Devices Market by Region 1.4.1 USA Pulmonary Drug Delivery Devices Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Northeast Status and Prospect (2012-2023) 1.4.3 Midwest Status and Prospect (2012-2023) 1.4.4 South Status and Prospect (2012-2023) 1.4.5 West Status and Prospect (2012-2023) 1.5 USA Sales and Revenue ofSales and Revenue of Pulmonary Drug Delivery Devices (2012-2023) 1.5.1 USA Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2023) 1.5.2 USA Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Pulmonary Drug Delivery Devices 2.2 Raw Material Analysis of Pulmonary Drug Delivery Devices 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Pulmonary Drug Delivery Devices 2.4 Other Costs Analysis of Pulmonary Drug Delivery Devices 2.5 Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices 2.6 Manufacturing Process Analysis of Pulmonary Drug Delivery Devices 2.7 Raw Materials Sources of Pulmonary Drug Delivery Devices Major Manufacturers in 2018 2.8 Downstream Buyers 3 USA Pulmonary Drug Delivery Devices Players/Suppliers Profiles and Sales Data 3.1 Boehringer Ingelheim GmbH 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Boehringer Ingelheim GmbH Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.1.5 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.2 Novartis AG 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Novartis AG Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.2.5 Novartis AG Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.3 GlaxoSmithKline 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 GlaxoSmithKline Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.3.5 GlaxoSmithKline Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.4 AstraZeneca 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 AstraZeneca Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.4.5 AstraZeneca Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.5 Teva Pharmaceutical Industries 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Teva Pharmaceutical Industries Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.5.5 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.6 Merck 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Merck Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Merck Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.6.5 Merck Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.7 MannKind 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 MannKind Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 MannKind Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.7.5 MannKind Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.8 Bristol-Myers Squibb 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Bristol-Myers Squibb Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.8.5 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.9 Mylan N.V 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Mylan N.V Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.9.5 Mylan N.V Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.10 Omron Corp 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Omron Corp Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.10.5 Omron Corp Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.11 F. Hoffmann-La Roche 3.12 3M Healthcare 3.13 Sunovion Pharmaceuticals 3.14 Koninklijke Philips N.V 3.15 Gerresheimer AG 4 USA Pulmonary Drug Delivery Devices Competition by Players/Manufacturers, Region, Type and Application 4.1 USA Pulmonary Drug Delivery Devices Market Competition by Players/Manufacturers 4.1.1 USA Pulmonary Drug Delivery Devices Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 USA Pulmonary Drug Delivery Devices Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 USA Pulmonary Drug Delivery Devices Sales and Revenue by Type 4.2.1 USA Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 USA Pulmonary Drug Delivery Devices Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 USA Pulmonary Drug Delivery Devices Sales and Revenue by Application 4.3.1 USA Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 USA Pulmonary Drug Delivery Devices Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 USA Pulmonary Drug Delivery Devices Sales (K Units) by Application 5 Northeast Pulmonary Drug Delivery Devices (Sales, Revenue and Price) 5.1 Northeast Pulmonary Drug Delivery Devices Sales and Value (2012-2017) 5.1.1 Northeast Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Northeast Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2017) 5.1.3 Northeast Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) 5.2 Northeast Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type 5.3 Northeast Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application 6 Midwest Pulmonary Drug Delivery Devices (Sales, Revenue and Price) 6.1 Midwest Pulmonary Drug Delivery Devices Sales and Value (2012-2017) 6.1.1 Midwest Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Midwest Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2017) 6.1.3 Midwest Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) 6.2 Midwest Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type 6.3 Midwest Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application 7 South Pulmonary Drug Delivery Devices (Sales, Revenue and Price) 7.1 South Pulmonary Drug Delivery Devices Sales and Value (2012-2017) 7.1.1 South Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2017) 7.1.3 South Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type 7.3 South Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application 8 West Pulmonary Drug Delivery Devices (Sales, Revenue and Price) 8.1 West Pulmonary Drug Delivery Devices Sales and Value (2012-2017) 8.1.1 West Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) 8.1.2 West Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2017) 8.1.3 West Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) 8.2 West Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type 8.3 West Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 USA Pulmonary Drug Delivery Devices Market Forecast (2018-2023) 12.1 USA Pulmonary Drug Delivery Devices Sales (K Units), Revenue and Price Forecast (2018-2023) 12.1.1 USA Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate Forecast (2018-2023) 12.1.2 USA Pulmonary Drug Delivery Devices Revenue and Growth Rate Forecast (2018-2023) 12.1.3 USA Pulmonary Drug Delivery Devices Price and Trend Forecast (2018-2023) 12.2 USA Pulmonary Drug Delivery Devices Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 USA Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 12.2.2 USA Pulmonary Drug Delivery Devices Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.3 Northeast Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Midwest Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 Midwest Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 West Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate Forecast (2018-2023) 12.3 USA Pulmonary Drug Delivery Devices Sales, Revenue and Price Forecast by Type (2018-2023) 12.3.1 USA Pulmonary Drug Delivery Devices Sales Forecast by Type (2018-2023) 12.3.2 USA Pulmonary Drug Delivery Devices Revenue Forecast by Type (2018-2023) 12.3.3 USA Pulmonary Drug Delivery Devices Price Forecast by Type (2018-2023) 12.4 USA Pulmonary Drug Delivery Devices Sales Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure USA Market Size (Million USD) Comparison 2012-2023 Table USA Market Pulmonary Drug Delivery Devices Revenue (Million USD) Comparison by Regions 2012-2023 Table USA Pulmonary Drug Delivery Devices Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table USA Pulmonary Drug Delivery Devices Sales (K Units) by Application (2016-2023) Figure Product Picture of Pulmonary Drug Delivery Devices Table USA Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure USA Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Types in 2017 Figure Dry Powder Inhaler Picture Figure Metered Dose Inhaler Picture Figure Nebulizer Picture Table USA Pulmonary Drug Delivery Devices Sales (K Units) Comparison by Applications (2012-2023) Figure USA Sales Market Share of Pulmonary Drug Delivery Devices by Applications in 2017 Figure Asthma Examples Figure COPD Examples Figure Cystic Fibrosis Examples Table USA Market Pulmonary Drug Delivery Devices Revenue (Million USD) Comparison by Regions 2012-2023 Figure Northeast Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure Midwest Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure South Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure West Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure USA Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2023) Figure USA Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Pulmonary Drug Delivery Devices Table Industry News List of Pulmonary Drug Delivery Devices Figure Industry Chain Structure of Pulmonary Drug Delivery Devices Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices in 2017 Figure Manufacturing Process Analysis of Pulmonary Drug Delivery Devices Table Raw Materials Sources of Pulmonary Drug Delivery Devices Major Manufacturers in 2017 Table Major Buyers of Pulmonary Drug Delivery Devices Table Boehringer Ingelheim GmbH Basic Information List Table Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales USA Market Share (%) (2012-2017) Figure Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Revenue USA Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Novartis AG Basic Information List Table Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis AG Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Novartis AG Pulmonary Drug Delivery Devices Sales USA Market Share (%) (2012-2017) Figure Novartis AG Pulmonary Drug Delivery Devices Revenue USA Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis AG Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Novartis AG Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Novartis AG Pulmonary Drug Delivery Devices Volume in and Its Application Share Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Pulmonary Drug Delivery Devices Sales USA Market Share (%) (2012-2017) Figure GlaxoSmithKline Pulmonary Drug Delivery Devices Revenue USA Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline Pulmonary Drug Delivery Devices Volume in and Its Application Share Table GlaxoSmithKline Pulmonary Drug Delivery Devices Volume in and Its Application Share Table GlaxoSmithKline Pulmonary Drug Delivery Devices Volume in and Its Application Share Table AstraZeneca Basic Information List Table AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure AstraZeneca Pulmonary Drug Delivery Devices Sales USA Market Share (%) (2012-2017) Figure AstraZeneca Pulmonary Drug Delivery Devices Revenue USA Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Pulmonary Drug Delivery Devices Volume in and Its Application Share Table AstraZeneca Pulmonary Drug Delivery Devices Volume in and Its Application Share Table AstraZeneca Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Teva Pharmaceutical Industries Basic Information List Table Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales USA Market Share (%) (2012-2017) Figure Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Revenue USA Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Merck Basic Information List Table Merck Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Merck Pulmonary Drug Delivery Devices Sales USA Market Share (%) (2012-2017) Figure Merck Pulmonary Drug Delivery Devices Revenue USA Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Merck Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Merck Pulmonary Drug Delivery Devices Volume in and Its Application Share Table MannKind Basic Information List Table MannKind Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure MannKind Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure MannKind Pulmonary Drug Delivery Devices Sales USA Market Share (%) (2012-2017) Figure MannKind Pulmonary Drug Delivery Devices Revenue USA Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table MannKind Pulmonary Drug Delivery Devices Volume in and Its Application Share Table MannKind Pulmonary Drug Delivery Devices Volume in and Its Application Share Table MannKind Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Bristol-Myers Squibb Basic Information List Table Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales USA Market Share (%) (2012-2017) Figure Bristol-Myers Squibb Pulmonary Drug Delivery Devices Revenue USA Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bristol-Myers Squibb Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Bristol-Myers Squibb Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Bristol-Myers Squibb Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Mylan N.V Basic Information List Table Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Mylan N.V Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Mylan N.V Pulmonary Drug Delivery Devices Sales USA Market Share (%) (2012-2017) Figure Mylan N.V Pulmonary Drug Delivery Devices Revenue USA Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Mylan N.V Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Mylan N.V Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Mylan N.V Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Company Omron Corp Basic Information List Table Company Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Omron Corp Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Company Omron Corp Pulmonary Drug Delivery Devices Sales USA Market Share (%) (2012-2017) Figure Company Omron Corp Pulmonary Drug Delivery Devices Revenue USA Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Omron Corp Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Company Omron Corp Pulmonary Drug Delivery Devices Volume in and Its Application Share Table Company Omron Corp Pulmonary Drug Delivery Devices Volume in and Its Application Share Table USA Pulmonary Drug Delivery Devices Sales (K Units) by Players/Manufacturers (2012-2017) Table USA Pulmonary Drug Delivery Devices Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 USA Pulmonary Drug Delivery Devices Sales Market Share (%) by Players/Manufacturers Figure 2017 USA Pulmonary Drug Delivery Devices Sales Share by Players/Manufacturers Table USA Pulmonary Drug Delivery Devices Revenue (Million USD) by Players/Manufacturers (2012-2017) Table USA Pulmonary Drug Delivery Devices Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 USA Pulmonary Drug Delivery Devices Revenue Market Share (%) Players Figure 2017 USA Pulmonary Drug Delivery Devices Revenue Market Share (%) Players Table USA Pulmonary Drug Delivery Devices Sales (K Units) and Market Share (%) by Type (2012-2017) Table USA Pulmonary Drug Delivery Devices Sales Share by Type (2012-2017) Figure Sales Market Share of Pulmonary Drug Delivery Devices by Type (2012-2017) Figure USA Pulmonary Drug Delivery Devices Sales Growth Rate (%) by Type (2012-2017) Table USA Pulmonary Drug Delivery Devices Revenue (Million USD) and Market Share (%) Type (2012-2017) Table USA Pulmonary Drug Delivery Devices Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Pulmonary Drug Delivery Devices by Type (2012-2017) Figure USA Pulmonary Drug Delivery Devices Revenue Growth Rate by Type (2012-2017) Table USA Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Regions (2012-2017) Table USA Pulmonary Drug Delivery Devices Sales Share by Regions (2012-2017) Figure Sales Market Share of Pulmonary Drug Delivery Devices by Regions (2012-2017) Figure USA Pulmonary Drug Delivery Devices Sales Market Share by Regions in 2017 Table USA Pulmonary Drug Delivery Devices Revenue (Million USD) and Market Share by Regions (2012-2017) Table USA Pulmonary Drug Delivery Devices Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Pulmonary Drug Delivery Devices by Regions (2012-2017) Figure USA Pulmonary Drug Delivery Devices Revenue Market Share by Regions in 2017 Table USA Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application (2012-2017) Table USA Pulmonary Drug Delivery Devices Sales Share (%) by Application (2012-2017) Figure USA Pulmonary Drug Delivery Devices Sales Market Share by Application (2012-2017) Figure USA Pulmonary Drug Delivery Devices Sales Market Share by Application (2012-2017) Figure Northeast Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) (2012-2017) Figure Northeast Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) Table Northeast Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017) Table Northeast Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type (2012-2017) Figure Northeast Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type in 2017 Table Northeast Pulmonary Drug Delivery Devices Sales (K Units) by Applications (2012-2017) Table Northeast Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications in 2017 Figure Midwest Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) Figure Midwest Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Midwest Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) Table Midwest Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017) Table Midwest Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type (2012-2017) Figure Midwest Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type in 2017 Table Midwest Pulmonary Drug Delivery Devices Sales (K Units) by Applications (2012-2017) Table Midwest Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications (2012-2017) Figure Midwest Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications in 2017 Figure South Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) Figure South Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) Table South Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017) Table South Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type (2012-2017) Figure South Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type in 2017 Table South Pulmonary Drug Delivery Devices Sales (K Units) by Applications (2012-2017) Table South Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications (2012-2017) Figure South Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications in 2017 Figure West Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) Figure West Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure West Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) Table West Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017) Table West Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type (2012-2017) Figure West Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type in 2017 Table West Pulmonary Drug Delivery Devices Sales (K Units) by Applications (2012-2017) Table West Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications (2012-2017) Figure West Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure USA Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate Forecast (2018-2023) Figure USA Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure USA Pulmonary Drug Delivery Devices Price and Trend Forecast (2018-2023) Table USA Pulmonary Drug Delivery Devices Sales (K Units) Forecast by Regions (2018-2023) Figure USA Pulmonary Drug Delivery Devices Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure USA Pulmonary Drug Delivery Devices Sales (K Units) Market Share Forecast by Regions in 2023 Table USA Pulmonary Drug Delivery Devices Revenue (Million USD) Forecast by Regions (2018-2023) Figure USA Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Regions (2018-2023) Figure USA Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Regions in 2023 Figure Northeast Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure West Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure West Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table USA Pulmonary Drug Delivery Devices Sales (K Units) Forecast by Type (2018-2023) Figure USA Pulmonary Drug Delivery Devices Sales Market Share Forecast by Type (2018-2023) Table USA Pulmonary Drug Delivery Devices Revenue (Million USD) Forecast by Type (2018-2023) Figure USA Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Type (2018-2023) Table USA Pulmonary Drug Delivery Devices Price (USD/Unit) Forecast by Type (2018-2023) Table USA Pulmonary Drug Delivery Devices Sales (K Units) Forecast by Application (2018-2023) Figure USA Pulmonary Drug Delivery Devices Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Boehringer Ingelheim GmbH Novartis AG GlaxoSmithKline AstraZeneca Teva Pharmaceutical Industries Merck MannKind Bristol-Myers Squibb Mylan N.V Omron Corp F. Hoffmann-La Roche 3M Healthcare Sunovion Pharmaceuticals Koninklijke Philips N.V Gerresheimer AG